Across TCGA pan-cancer cohorts, ARF4P3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ARF4P3’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ARF4P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ARF4P3 is over-expressed in tumor.

COAD and BRCA are the cancer types where ARF4P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ARF4P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.072	.042	4	view →
BRCA	All	II,III,IV	+0.006	.024	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ARF4P3 RNA expression & survival · all ARF4P3 data types